Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial. (Q27852333)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial. |
scientific article |
Statements
2 references
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial (English)
Krzysztof Skladowski
Arlene A Forastiere
Jan B Vermorken
Jan Stöhlmacher-Williams
Irina Davidenko
Eric Winquist
Cristian Villanueva
Paolo Foa
Sylvie Rottey
Makoto Tahara
Vasant R Pai
Cesar R Blajman
Kelly S Oliner
Zhiying Pan
SPECTRUM investigators
Identifiers
2 references
2 references